nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP1A2—Imiquimod—skin cancer	0.188	0.235	CbGbCtD
Moclobemide—CYP2C19—Vismodegib—skin cancer	0.141	0.176	CbGbCtD
Moclobemide—CYP2C9—Vismodegib—skin cancer	0.117	0.146	CbGbCtD
Moclobemide—CYP1A2—Vemurafenib—skin cancer	0.103	0.129	CbGbCtD
Moclobemide—CYP2D6—Vemurafenib—skin cancer	0.0847	0.106	CbGbCtD
Moclobemide—CYP1A2—Dacarbazine—skin cancer	0.0788	0.0985	CbGbCtD
Moclobemide—CYP1A2—Fluorouracil—skin cancer	0.0462	0.0577	CbGbCtD
Moclobemide—CYP2C9—Fluorouracil—skin cancer	0.0416	0.052	CbGbCtD
Moclobemide—Rectal tenesmus—Imiquimod—skin cancer	0.00669	0.0338	CcSEcCtD
Moclobemide—Proctalgia—Imiquimod—skin cancer	0.00531	0.0269	CcSEcCtD
Moclobemide—Hepatic enzyme increased—Vismodegib—skin cancer	0.005	0.0253	CcSEcCtD
Moclobemide—Anorectal discomfort—Imiquimod—skin cancer	0.00456	0.023	CcSEcCtD
Moclobemide—Photopsia—Docetaxel—skin cancer	0.00312	0.0158	CcSEcCtD
Moclobemide—Hepatic enzyme increased—Imiquimod—skin cancer	0.00263	0.0133	CcSEcCtD
Moclobemide—Procainamide—SCN10A—skin cancer	0.00244	1	CrCbGaD
Moclobemide—Apathy—Temozolomide—skin cancer	0.00209	0.0106	CcSEcCtD
Moclobemide—Flat affect—Temozolomide—skin cancer	0.00207	0.0105	CcSEcCtD
Moclobemide—Dysgeusia—Vismodegib—skin cancer	0.00202	0.0102	CcSEcCtD
Moclobemide—Aggression—Bleomycin—skin cancer	0.00201	0.0102	CcSEcCtD
Moclobemide—Heartburn—Fluorouracil—skin cancer	0.002	0.0101	CcSEcCtD
Moclobemide—Dry skin—Vemurafenib—skin cancer	0.00194	0.00983	CcSEcCtD
Moclobemide—Migraine—Imiquimod—skin cancer	0.00178	0.009	CcSEcCtD
Moclobemide—Myalgia—Vismodegib—skin cancer	0.00176	0.0089	CcSEcCtD
Moclobemide—Irritability—Imiquimod—skin cancer	0.00173	0.00873	CcSEcCtD
Moclobemide—Hepatic enzyme increased—Temozolomide—skin cancer	0.00158	0.00798	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00154	0.00777	CcSEcCtD
Moclobemide—Dyspepsia—Vismodegib—skin cancer	0.00149	0.00751	CcSEcCtD
Moclobemide—Decreased appetite—Vismodegib—skin cancer	0.00147	0.00742	CcSEcCtD
Moclobemide—Dysuria—Imiquimod—skin cancer	0.00146	0.00739	CcSEcCtD
Moclobemide—Fatigue—Vismodegib—skin cancer	0.00145	0.00736	CcSEcCtD
Moclobemide—Dysarthria—Fluorouracil—skin cancer	0.00145	0.00736	CcSEcCtD
Moclobemide—Heartburn—Docetaxel—skin cancer	0.00144	0.0073	CcSEcCtD
Moclobemide—Constipation—Vismodegib—skin cancer	0.00144	0.0073	CcSEcCtD
Moclobemide—Disorientation—Bleomycin—skin cancer	0.00144	0.00726	CcSEcCtD
Moclobemide—Gastrointestinal pain—Vismodegib—skin cancer	0.00138	0.00698	CcSEcCtD
Moclobemide—Conjunctivitis—Imiquimod—skin cancer	0.00136	0.00685	CcSEcCtD
Moclobemide—Dermatitis atopic—Docetaxel—skin cancer	0.00134	0.00678	CcSEcCtD
Moclobemide—Abdominal pain—Vismodegib—skin cancer	0.00133	0.00675	CcSEcCtD
Moclobemide—Dysgeusia—Vemurafenib—skin cancer	0.00125	0.00633	CcSEcCtD
Moclobemide—Asthenia—Vismodegib—skin cancer	0.00121	0.00612	CcSEcCtD
Moclobemide—Visual impairment—Imiquimod—skin cancer	0.00121	0.0061	CcSEcCtD
Moclobemide—Pruritus—Vismodegib—skin cancer	0.00119	0.00604	CcSEcCtD
Moclobemide—Tinnitus—Imiquimod—skin cancer	0.00117	0.0059	CcSEcCtD
Moclobemide—Flushing—Imiquimod—skin cancer	0.00116	0.00587	CcSEcCtD
Moclobemide—Hot flush—Temozolomide—skin cancer	0.00116	0.00586	CcSEcCtD
Moclobemide—Diarrhoea—Vismodegib—skin cancer	0.00115	0.00584	CcSEcCtD
Moclobemide—Menopausal symptoms—Temozolomide—skin cancer	0.00115	0.00581	CcSEcCtD
Moclobemide—Disorientation—Fluorouracil—skin cancer	0.00112	0.00565	CcSEcCtD
Moclobemide—Myalgia—Vemurafenib—skin cancer	0.00109	0.0055	CcSEcCtD
Moclobemide—Vomiting—Vismodegib—skin cancer	0.00107	0.00543	CcSEcCtD
Moclobemide—Rash—Vismodegib—skin cancer	0.00106	0.00538	CcSEcCtD
Moclobemide—Dermatitis—Vismodegib—skin cancer	0.00106	0.00538	CcSEcCtD
Moclobemide—Ill-defined disorder—Imiquimod—skin cancer	0.00101	0.00511	CcSEcCtD
Moclobemide—Nausea—Vismodegib—skin cancer	0.001	0.00507	CcSEcCtD
Moclobemide—Agitation—Imiquimod—skin cancer	0.001	0.00506	CcSEcCtD
Moclobemide—Osteoarthritis—Fluorouracil—skin cancer	0.000999	0.00505	CcSEcCtD
Moclobemide—Dry skin—Temozolomide—skin cancer	0.000994	0.00502	CcSEcCtD
Moclobemide—Malaise—Imiquimod—skin cancer	0.000982	0.00497	CcSEcCtD
Moclobemide—Syncope—Imiquimod—skin cancer	0.000977	0.00494	CcSEcCtD
Moclobemide—Hypotension—Vemurafenib—skin cancer	0.000974	0.00493	CcSEcCtD
Moclobemide—Stomatitis—Bleomycin—skin cancer	0.000965	0.00488	CcSEcCtD
Moclobemide—Palpitations—Imiquimod—skin cancer	0.000963	0.00487	CcSEcCtD
Moclobemide—Loss of consciousness—Imiquimod—skin cancer	0.000958	0.00484	CcSEcCtD
Moclobemide—Irritability—Fluorouracil—skin cancer	0.000953	0.00482	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00095	0.0048	CcSEcCtD
Moclobemide—Abdominal distension—Temozolomide—skin cancer	0.000943	0.00477	CcSEcCtD
Moclobemide—Hypertension—Imiquimod—skin cancer	0.000941	0.00476	CcSEcCtD
Moclobemide—Myalgia—Imiquimod—skin cancer	0.000927	0.00469	CcSEcCtD
Moclobemide—Chest pain—Imiquimod—skin cancer	0.000927	0.00469	CcSEcCtD
Moclobemide—Anxiety—Imiquimod—skin cancer	0.000924	0.00467	CcSEcCtD
Moclobemide—Discomfort—Imiquimod—skin cancer	0.000916	0.00463	CcSEcCtD
Moclobemide—Dry skin—Fluorouracil—skin cancer	0.000916	0.00463	CcSEcCtD
Moclobemide—Dry mouth—Imiquimod—skin cancer	0.000907	0.00459	CcSEcCtD
Moclobemide—Decreased appetite—Vemurafenib—skin cancer	0.000906	0.00458	CcSEcCtD
Moclobemide—Stomatitis—Dactinomycin—skin cancer	0.0009	0.00455	CcSEcCtD
Moclobemide—Fatigue—Vemurafenib—skin cancer	0.000899	0.00455	CcSEcCtD
Moclobemide—Constipation—Vemurafenib—skin cancer	0.000892	0.00451	CcSEcCtD
Moclobemide—Dysuria—Temozolomide—skin cancer	0.000876	0.00443	CcSEcCtD
Moclobemide—Shock—Imiquimod—skin cancer	0.000875	0.00442	CcSEcCtD
Moclobemide—Tachycardia—Imiquimod—skin cancer	0.000868	0.00439	CcSEcCtD
Moclobemide—Hyperhidrosis—Imiquimod—skin cancer	0.00086	0.00435	CcSEcCtD
Moclobemide—Angina pectoris—Fluorouracil—skin cancer	0.000841	0.00425	CcSEcCtD
Moclobemide—Flushing—Bleomycin—skin cancer	0.000825	0.00417	CcSEcCtD
Moclobemide—Stomatitis—Temozolomide—skin cancer	0.000814	0.00412	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00081	0.0041	CcSEcCtD
Moclobemide—Insomnia—Imiquimod—skin cancer	0.000804	0.00407	CcSEcCtD
Moclobemide—Paraesthesia—Imiquimod—skin cancer	0.000798	0.00404	CcSEcCtD
Moclobemide—Dyspnoea—Imiquimod—skin cancer	0.000793	0.00401	CcSEcCtD
Moclobemide—Somnolence—Imiquimod—skin cancer	0.00079	0.004	CcSEcCtD
Moclobemide—Dyspepsia—Imiquimod—skin cancer	0.000783	0.00396	CcSEcCtD
Moclobemide—Decreased appetite—Imiquimod—skin cancer	0.000773	0.00391	CcSEcCtD
Moclobemide—Hot flush—Docetaxel—skin cancer	0.000771	0.0039	CcSEcCtD
Moclobemide—Flushing—Dactinomycin—skin cancer	0.00077	0.00389	CcSEcCtD
Moclobemide—Fatigue—Imiquimod—skin cancer	0.000767	0.00388	CcSEcCtD
Moclobemide—Menopausal symptoms—Docetaxel—skin cancer	0.000764	0.00386	CcSEcCtD
Moclobemide—Visual disturbance—Docetaxel—skin cancer	0.000761	0.00385	CcSEcCtD
Moclobemide—Stomatitis—Fluorouracil—skin cancer	0.00075	0.00379	CcSEcCtD
Moclobemide—Conjunctivitis—Fluorouracil—skin cancer	0.000748	0.00378	CcSEcCtD
Moclobemide—Asthenia—Vemurafenib—skin cancer	0.000748	0.00378	CcSEcCtD
Moclobemide—Hallucination—Temozolomide—skin cancer	0.000746	0.00377	CcSEcCtD
Moclobemide—Pruritus—Vemurafenib—skin cancer	0.000738	0.00373	CcSEcCtD
Moclobemide—Feeling abnormal—Imiquimod—skin cancer	0.000733	0.0037	CcSEcCtD
Moclobemide—Gastrointestinal pain—Imiquimod—skin cancer	0.000727	0.00368	CcSEcCtD
Moclobemide—Visual impairment—Temozolomide—skin cancer	0.000723	0.00365	CcSEcCtD
Moclobemide—Ill-defined disorder—Bleomycin—skin cancer	0.000718	0.00363	CcSEcCtD
Moclobemide—Diarrhoea—Vemurafenib—skin cancer	0.000713	0.00361	CcSEcCtD
Moclobemide—Migraine—Docetaxel—skin cancer	0.00071	0.00359	CcSEcCtD
Moclobemide—Urticaria—Imiquimod—skin cancer	0.000706	0.00357	CcSEcCtD
Moclobemide—Abdominal pain—Imiquimod—skin cancer	0.000703	0.00355	CcSEcCtD
Moclobemide—Tinnitus—Temozolomide—skin cancer	0.000699	0.00354	CcSEcCtD
Moclobemide—Malaise—Bleomycin—skin cancer	0.000698	0.00353	CcSEcCtD
Moclobemide—Flushing—Temozolomide—skin cancer	0.000696	0.00352	CcSEcCtD
Moclobemide—Dizziness—Vemurafenib—skin cancer	0.000689	0.00349	CcSEcCtD
Moclobemide—Ill-defined disorder—Dactinomycin—skin cancer	0.00067	0.00339	CcSEcCtD
Moclobemide—Vomiting—Vemurafenib—skin cancer	0.000663	0.00335	CcSEcCtD
Moclobemide—Dry skin—Docetaxel—skin cancer	0.000661	0.00334	CcSEcCtD
Moclobemide—Chest pain—Bleomycin—skin cancer	0.000659	0.00333	CcSEcCtD
Moclobemide—Myalgia—Bleomycin—skin cancer	0.000659	0.00333	CcSEcCtD
Moclobemide—Rash—Vemurafenib—skin cancer	0.000657	0.00332	CcSEcCtD
Moclobemide—Dermatitis—Vemurafenib—skin cancer	0.000657	0.00332	CcSEcCtD
Moclobemide—Headache—Vemurafenib—skin cancer	0.000653	0.0033	CcSEcCtD
Moclobemide—Discomfort—Bleomycin—skin cancer	0.000651	0.00329	CcSEcCtD
Moclobemide—Malaise—Dactinomycin—skin cancer	0.000651	0.00329	CcSEcCtD
Moclobemide—Dysgeusia—Temozolomide—skin cancer	0.000639	0.00323	CcSEcCtD
Moclobemide—Asthenia—Imiquimod—skin cancer	0.000638	0.00323	CcSEcCtD
Moclobemide—Confusional state—Bleomycin—skin cancer	0.000637	0.00322	CcSEcCtD
Moclobemide—Pruritus—Imiquimod—skin cancer	0.000629	0.00318	CcSEcCtD
Moclobemide—Nausea—Vemurafenib—skin cancer	0.000619	0.00313	CcSEcCtD
Moclobemide—Vision blurred—Temozolomide—skin cancer	0.000615	0.00311	CcSEcCtD
Moclobemide—Myalgia—Dactinomycin—skin cancer	0.000615	0.00311	CcSEcCtD
Moclobemide—Tremor—Temozolomide—skin cancer	0.000612	0.00309	CcSEcCtD
Moclobemide—Diarrhoea—Imiquimod—skin cancer	0.000608	0.00308	CcSEcCtD
Moclobemide—Discomfort—Dactinomycin—skin cancer	0.000607	0.00307	CcSEcCtD
Moclobemide—Angina pectoris—Docetaxel—skin cancer	0.000607	0.00307	CcSEcCtD
Moclobemide—Ill-defined disorder—Temozolomide—skin cancer	0.000606	0.00306	CcSEcCtD
Moclobemide—Agitation—Temozolomide—skin cancer	0.0006	0.00303	CcSEcCtD
Moclobemide—Hypotension—Bleomycin—skin cancer	0.00059	0.00298	CcSEcCtD
Moclobemide—Malaise—Temozolomide—skin cancer	0.000589	0.00298	CcSEcCtD
Moclobemide—Dizziness—Imiquimod—skin cancer	0.000588	0.00297	CcSEcCtD
Moclobemide—Palpitations—Temozolomide—skin cancer	0.000577	0.00292	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000575	0.00291	CcSEcCtD
Moclobemide—Paraesthesia—Bleomycin—skin cancer	0.000567	0.00287	CcSEcCtD
Moclobemide—Vision blurred—Fluorouracil—skin cancer	0.000567	0.00287	CcSEcCtD
Moclobemide—Vomiting—Imiquimod—skin cancer	0.000565	0.00286	CcSEcCtD
Moclobemide—Hypertension—Temozolomide—skin cancer	0.000564	0.00285	CcSEcCtD
Moclobemide—Dyspnoea—Bleomycin—skin cancer	0.000563	0.00285	CcSEcCtD
Moclobemide—Rash—Imiquimod—skin cancer	0.000561	0.00283	CcSEcCtD
Moclobemide—Dermatitis—Imiquimod—skin cancer	0.00056	0.00283	CcSEcCtD
Moclobemide—Headache—Imiquimod—skin cancer	0.000557	0.00282	CcSEcCtD
Moclobemide—Myalgia—Temozolomide—skin cancer	0.000556	0.00281	CcSEcCtD
Moclobemide—Anxiety—Temozolomide—skin cancer	0.000554	0.0028	CcSEcCtD
Moclobemide—Discomfort—Temozolomide—skin cancer	0.000549	0.00278	CcSEcCtD
Moclobemide—Decreased appetite—Bleomycin—skin cancer	0.000549	0.00278	CcSEcCtD
Moclobemide—Dry mouth—Temozolomide—skin cancer	0.000544	0.00275	CcSEcCtD
Moclobemide—Stomatitis—Docetaxel—skin cancer	0.000542	0.00274	CcSEcCtD
Moclobemide—Conjunctivitis—Docetaxel—skin cancer	0.00054	0.00273	CcSEcCtD
Moclobemide—Confusional state—Temozolomide—skin cancer	0.000537	0.00272	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000537	0.00271	CcSEcCtD
Moclobemide—Nausea—Imiquimod—skin cancer	0.000528	0.00267	CcSEcCtD
Moclobemide—Feeling abnormal—Bleomycin—skin cancer	0.000521	0.00263	CcSEcCtD
Moclobemide—Hyperhidrosis—Temozolomide—skin cancer	0.000515	0.0026	CcSEcCtD
Moclobemide—Myalgia—Fluorouracil—skin cancer	0.000512	0.00259	CcSEcCtD
Moclobemide—Chest pain—Fluorouracil—skin cancer	0.000512	0.00259	CcSEcCtD
Moclobemide—Decreased appetite—Dactinomycin—skin cancer	0.000512	0.00259	CcSEcCtD
Moclobemide—Fatigue—Dactinomycin—skin cancer	0.000508	0.00257	CcSEcCtD
Moclobemide—Discomfort—Fluorouracil—skin cancer	0.000506	0.00256	CcSEcCtD
Moclobemide—Urticaria—Bleomycin—skin cancer	0.000502	0.00254	CcSEcCtD
Moclobemide—Confusional state—Fluorouracil—skin cancer	0.000495	0.0025	CcSEcCtD
Moclobemide—Feeling abnormal—Dactinomycin—skin cancer	0.000485	0.00245	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000485	0.00245	CcSEcCtD
Moclobemide—Insomnia—Temozolomide—skin cancer	0.000482	0.00244	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dactinomycin—skin cancer	0.000482	0.00244	CcSEcCtD
Moclobemide—Visual impairment—Docetaxel—skin cancer	0.000481	0.00243	CcSEcCtD
Moclobemide—Tachycardia—Fluorouracil—skin cancer	0.000479	0.00242	CcSEcCtD
Moclobemide—Paraesthesia—Temozolomide—skin cancer	0.000478	0.00242	CcSEcCtD
Moclobemide—Dyspnoea—Temozolomide—skin cancer	0.000475	0.0024	CcSEcCtD
Moclobemide—Somnolence—Temozolomide—skin cancer	0.000474	0.0024	CcSEcCtD
Moclobemide—Dyspepsia—Temozolomide—skin cancer	0.000469	0.00237	CcSEcCtD
Moclobemide—Abdominal pain—Dactinomycin—skin cancer	0.000466	0.00235	CcSEcCtD
Moclobemide—Decreased appetite—Temozolomide—skin cancer	0.000463	0.00234	CcSEcCtD
Moclobemide—Flushing—Docetaxel—skin cancer	0.000463	0.00234	CcSEcCtD
Moclobemide—Fatigue—Temozolomide—skin cancer	0.000459	0.00232	CcSEcCtD
Moclobemide—Hypotension—Fluorouracil—skin cancer	0.000459	0.00232	CcSEcCtD
Moclobemide—Constipation—Temozolomide—skin cancer	0.000456	0.0023	CcSEcCtD
Moclobemide—Asthenia—Bleomycin—skin cancer	0.000453	0.00229	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000447	0.00226	CcSEcCtD
Moclobemide—Pruritus—Bleomycin—skin cancer	0.000447	0.00226	CcSEcCtD
Moclobemide—Insomnia—Fluorouracil—skin cancer	0.000444	0.00225	CcSEcCtD
Moclobemide—Paraesthesia—Fluorouracil—skin cancer	0.000441	0.00223	CcSEcCtD
Moclobemide—Feeling abnormal—Temozolomide—skin cancer	0.000439	0.00222	CcSEcCtD
Moclobemide—Dyspnoea—Fluorouracil—skin cancer	0.000438	0.00221	CcSEcCtD
Moclobemide—Somnolence—Fluorouracil—skin cancer	0.000436	0.00221	CcSEcCtD
Moclobemide—Gastrointestinal pain—Temozolomide—skin cancer	0.000436	0.0022	CcSEcCtD
Moclobemide—Dyspepsia—Fluorouracil—skin cancer	0.000432	0.00219	CcSEcCtD
Moclobemide—Decreased appetite—Fluorouracil—skin cancer	0.000427	0.00216	CcSEcCtD
Moclobemide—Dysgeusia—Docetaxel—skin cancer	0.000425	0.00215	CcSEcCtD
Moclobemide—Urticaria—Temozolomide—skin cancer	0.000423	0.00214	CcSEcCtD
Moclobemide—Asthenia—Dactinomycin—skin cancer	0.000423	0.00214	CcSEcCtD
Moclobemide—Abdominal pain—Temozolomide—skin cancer	0.000421	0.00213	CcSEcCtD
Moclobemide—Feeling abnormal—Fluorouracil—skin cancer	0.000405	0.00205	CcSEcCtD
Moclobemide—Diarrhoea—Dactinomycin—skin cancer	0.000403	0.00204	CcSEcCtD
Moclobemide—Vomiting—Bleomycin—skin cancer	0.000402	0.00203	CcSEcCtD
Moclobemide—Rash—Bleomycin—skin cancer	0.000398	0.00201	CcSEcCtD
Moclobemide—Dermatitis—Bleomycin—skin cancer	0.000398	0.00201	CcSEcCtD
Moclobemide—Urticaria—Fluorouracil—skin cancer	0.00039	0.00197	CcSEcCtD
Moclobemide—Syncope—Docetaxel—skin cancer	0.000389	0.00197	CcSEcCtD
Moclobemide—Palpitations—Docetaxel—skin cancer	0.000384	0.00194	CcSEcCtD
Moclobemide—Asthenia—Temozolomide—skin cancer	0.000382	0.00193	CcSEcCtD
Moclobemide—Loss of consciousness—Docetaxel—skin cancer	0.000382	0.00193	CcSEcCtD
Moclobemide—Pruritus—Temozolomide—skin cancer	0.000377	0.00191	CcSEcCtD
Moclobemide—Nausea—Bleomycin—skin cancer	0.000375	0.0019	CcSEcCtD
Moclobemide—Hypertension—Docetaxel—skin cancer	0.000375	0.0019	CcSEcCtD
Moclobemide—Vomiting—Dactinomycin—skin cancer	0.000375	0.00189	CcSEcCtD
Moclobemide—Rash—Dactinomycin—skin cancer	0.000371	0.00188	CcSEcCtD
Moclobemide—Myalgia—Docetaxel—skin cancer	0.00037	0.00187	CcSEcCtD
Moclobemide—Chest pain—Docetaxel—skin cancer	0.00037	0.00187	CcSEcCtD
Moclobemide—Diarrhoea—Temozolomide—skin cancer	0.000365	0.00184	CcSEcCtD
Moclobemide—Dry mouth—Docetaxel—skin cancer	0.000361	0.00183	CcSEcCtD
Moclobemide—Confusional state—Docetaxel—skin cancer	0.000357	0.00181	CcSEcCtD
Moclobemide—Dizziness—Temozolomide—skin cancer	0.000352	0.00178	CcSEcCtD
Moclobemide—Nausea—Dactinomycin—skin cancer	0.00035	0.00177	CcSEcCtD
Moclobemide—Shock—Docetaxel—skin cancer	0.000349	0.00176	CcSEcCtD
Moclobemide—Pruritus—Fluorouracil—skin cancer	0.000347	0.00176	CcSEcCtD
Moclobemide—Tachycardia—Docetaxel—skin cancer	0.000346	0.00175	CcSEcCtD
Moclobemide—Vomiting—Temozolomide—skin cancer	0.000339	0.00171	CcSEcCtD
Moclobemide—Rash—Temozolomide—skin cancer	0.000336	0.0017	CcSEcCtD
Moclobemide—Diarrhoea—Fluorouracil—skin cancer	0.000336	0.0017	CcSEcCtD
Moclobemide—Dermatitis—Temozolomide—skin cancer	0.000336	0.0017	CcSEcCtD
Moclobemide—Headache—Temozolomide—skin cancer	0.000334	0.00169	CcSEcCtD
Moclobemide—Hypotension—Docetaxel—skin cancer	0.000331	0.00167	CcSEcCtD
Moclobemide—Dizziness—Fluorouracil—skin cancer	0.000325	0.00164	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000323	0.00163	CcSEcCtD
Moclobemide—Insomnia—Docetaxel—skin cancer	0.00032	0.00162	CcSEcCtD
Moclobemide—Paraesthesia—Docetaxel—skin cancer	0.000318	0.00161	CcSEcCtD
Moclobemide—Nausea—Temozolomide—skin cancer	0.000316	0.0016	CcSEcCtD
Moclobemide—Dyspnoea—Docetaxel—skin cancer	0.000316	0.0016	CcSEcCtD
Moclobemide—Somnolence—Docetaxel—skin cancer	0.000315	0.00159	CcSEcCtD
Moclobemide—Vomiting—Fluorouracil—skin cancer	0.000312	0.00158	CcSEcCtD
Moclobemide—Dyspepsia—Docetaxel—skin cancer	0.000312	0.00158	CcSEcCtD
Moclobemide—Rash—Fluorouracil—skin cancer	0.00031	0.00157	CcSEcCtD
Moclobemide—Dermatitis—Fluorouracil—skin cancer	0.000309	0.00156	CcSEcCtD
Moclobemide—Decreased appetite—Docetaxel—skin cancer	0.000308	0.00156	CcSEcCtD
Moclobemide—Headache—Fluorouracil—skin cancer	0.000308	0.00156	CcSEcCtD
Moclobemide—Fatigue—Docetaxel—skin cancer	0.000305	0.00154	CcSEcCtD
Moclobemide—Constipation—Docetaxel—skin cancer	0.000303	0.00153	CcSEcCtD
Moclobemide—Feeling abnormal—Docetaxel—skin cancer	0.000292	0.00148	CcSEcCtD
Moclobemide—Nausea—Fluorouracil—skin cancer	0.000292	0.00147	CcSEcCtD
Moclobemide—Gastrointestinal pain—Docetaxel—skin cancer	0.00029	0.00147	CcSEcCtD
Moclobemide—Abdominal pain—Docetaxel—skin cancer	0.00028	0.00142	CcSEcCtD
Moclobemide—Asthenia—Docetaxel—skin cancer	0.000254	0.00129	CcSEcCtD
Moclobemide—Pruritus—Docetaxel—skin cancer	0.000251	0.00127	CcSEcCtD
Moclobemide—Diarrhoea—Docetaxel—skin cancer	0.000242	0.00123	CcSEcCtD
Moclobemide—Dizziness—Docetaxel—skin cancer	0.000234	0.00118	CcSEcCtD
Moclobemide—Vomiting—Docetaxel—skin cancer	0.000225	0.00114	CcSEcCtD
Moclobemide—Rash—Docetaxel—skin cancer	0.000223	0.00113	CcSEcCtD
Moclobemide—Dermatitis—Docetaxel—skin cancer	0.000223	0.00113	CcSEcCtD
Moclobemide—Headache—Docetaxel—skin cancer	0.000222	0.00112	CcSEcCtD
Moclobemide—Nausea—Docetaxel—skin cancer	0.00021	0.00106	CcSEcCtD
